Experts take strong stance on testosterone deficiency and treatment

June 21, 2016, Beth Israel Deaconess Medical Center

In an effort to address widespread concerns related to testosterone deficiency (TD) and its treatment with testosterone therapy, a group of international experts has developed a set of resolutions and conclusions to provide clarity for physicians and patients. At a consensus conference held in Prague, Czech Republic last fall, the experts debated nine resolutions, with unanimous approval. The details of the conference were published today in a Mayo Clinic Proceedings report.

Much of the controversy surrounding stems from intense media attention on recent reports suggesting increased heart-related risks associated with . "The importance of this meeting was to set aside the various distortions and misinformation that have appeared regarding testosterone therapy and to establish what is scientifically true based on the best available evidence," said Abraham Morgentaler, MD, chairman of the consensus conference. Morgentaler is the Director of Men's Health Boston and an Associate Clinical Professor of Urology at Beth Israel Deaconess Medical Center and Harvard Medical School.

After examining the best available scientific evidence, Morgentaler and colleagues—who included experts with specialties in urology, endocrinology, diabetes, internal medicine, and basic science research—agreed on the following:

  • TD is a well-established, clinically significant medical condition that negatively affects male sexuality, reproduction, general health and quality of life.
  • Symptoms and signs of TD occur as a result of low levels of testosterone and may benefit from treatment regardless of whether there is an identified underlying origin.
  • TD is a global public health concern.
  • Testosterone therapy for men with TD is effective, rational, and evidence-based.
  • There is no testosterone concentration threshold that reliably distinguishes those who will respond to treatment from those who will not.
  • There is no scientific basis for any age-specific recommendations against the use of testosterone therapy in adult males.
  • The evidence does not support increased risks of cardiovascular events with testosterone therapy.
  • The evidence does not support increased risk of prostate cancer with testosterone therapy.
  • The evidence supports a major research initiative to explore possible benefits of testosterone therapy for cardiometabolic disease, including diabetes.

"It will be surprising to those unfamiliar with the literature to learn how weak the evidence is supporting the alleged risks of cardiovascular disease and ," said Michael Zitzmann, MD, vice-chair of the conference and a Professor in the Centre for Reproductive Medicine and Andrology at the University of Muenster in Germany. "Indeed, there is substantial data suggesting there may actually be cardio-protective benefits of testosterone therapy."

"The medical and scientific communities are still largely unaware of the major negative impact of testosterone deficiency on ," added co-author Abdulmaged Traish, PhD, a Professor of Urology at Boston University Medical Center. "The media-driven focus on unproven risks has obscured the known health risks of untreated deficiency: obesity, reduced bone mineral density, and increased mortality."

Explore further: Testosterone undecanoate cuts anemia in hypogonadal men

Related Stories

Testosterone undecanoate cuts anemia in hypogonadal men

April 18, 2016
(HealthDay)—Testosterone undecanoate reduces anemia in patients with subnormal testosterone levels, according to a study published in the April issue of The Journal of Urology.

No credible evidence to support cardiac risk of testosterone therapy

May 5, 2014
Recent articles in the scientific literature and mass media that question the use of testosterone (T) therapy to treat T deficiency, or "low T," and assert the cardiovascular risks of T therapy, are flawed, according to a ...

Testosterone undecanoate improves sexual function in men with type 2 diabetes

May 6, 2016
In a recent placebo-controlled study, long acting testosterone undecanoate (an ester of testosterone) improved erectile function, intercourse satisfaction, and sexual desire scores in type 2 diabetic men with severe hypogonadism, ...

New recommendations addresses the diagnosis and management of testosterone deficiency

July 9, 2015
An expert panel convened by the International Society for Sexual Medicine has developed a detailed "Process of Care" for the diagnosis and management of testosterone deficiency in men.

Study shows testosterone therapy does not increase aggressive prostate cancer risk

October 5, 2015
A new population-based study from The University of Texas Medical Branch at Galveston showed for the first time that exposure to testosterone therapy over a five-year period was not associated with an increased risk of aggressive ...

Difficult to predict low testosterone in older men using data on younger men

June 20, 2016
A new study published in CMAJ (Canadian Medical Association Journal) highlights the difficulty in defining and managing age-related testosterone decline in older men.

Recommended for you

Exercise-induced hormone irisin triggers bone remodeling in mice

December 13, 2018
Exercise has been touted to build bone mass, but exactly how it actually accomplishes this is a matter of debate. Now, researchers show that an exercise-induced hormone activates cells that are critical for bone remodeling ...

Law professor suggests a way to validate and integrate deep learning medical systems

December 13, 2018
University of Michigan professor W. Nicholson Price, who also has affiliations with Harvard Law School and the University of Copenhagen Faculty of Law, suggests in a Focus piece published in Science Translational Medicine, ...

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

Pain: Perception and motor impulses arise in brain independently of one another

December 13, 2018
Pain is a negative sensation that we want to get rid of as soon as possible. In order to protect our bodies, we react by withdrawing the hand from heat, for example. This action is usually understood as the consequence of ...

Drug targets for Ebola, Dengue, and Zika viruses found in lab study

December 13, 2018
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes ...

Researchers give new insight to muscular dystrophy patients

December 13, 2018
New research by University of Minnesota scientists has revealed the three-dimensional structure of the DUX4 protein, which is responsible for the disease, facioscapulohumeral muscular dystrophy (FSHD). Unlike the majority ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.